GMR001 HYPERCAR TESTING REACHES NEW PHASE WITH FIRST PERFORMANCE AND WET WEATHER RUNNING
Testing of the GMR-001 Hypercar entered a new phase last week at…
CoinW’s CrazyEarn: Transforming Idle Funds into Active Earnings
HONG KONG, Nov. 12, 2025 /PRNewswire/ -- CoinW, a leading global crypto…
Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
November 08, 2025 17:13 ET | Source: Intellia Therapeutics, Inc. Deep, stable…
Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive…
Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
Two oral and seven poster presentations further support the CARVYKTI® research in…
Mutuum Finance (MUTM) Progresses Through Roadmap Phase 2 as It Attracts Over 17,600 Participants
Dubai, UAE, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM) continues to…
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase…
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
October 31, 2025 16:30 ET | Source: FibroBiologics, Inc. Advancing preparations to…
Hyundai Motor Group Announces NVIDIA Blackwell AI Factory to Power Fleet of AIDriven Mobility Solutions
Hyundai Motor Group and NVIDIA will collaborate with the Korean government to…
ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection
SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")…